The immune enhancement of propolis adjuvant on inactivated porcine parvovirus vaccine in guinea pig

Cellular Immunology

Volumn 270, Issue 1, 2011, Pages 13-18

  Ma, Xia ^a,b   Guo, Zhenhuan ^a,b   Shen, Zhiqiang ^b   Wang, Jinliang ^b   Hu, Yuanliang ^a   Wang, Deyun ^a  

^a NANJING AGRICULTURAL UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG FIRST MEDICAL UNIVERSITY   (China)

Author keywords

Cellular immunity; Humoral immunity; Immune effect; Inactivated porcine parvovirus vaccine; Propolis

Indexed keywords

ALUMINUM SALT; INACTIVATED PORCINE PARVOVIRUS VACCINE; INACTIVATED VACCINE; INTERLEUKIN 2; INTERLEUKIN 4; OIL; PROPOLIS; UNCLASSIFIED DRUG; VIRUS VACCINE;

ADJUVANT THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; CELLULAR IMMUNITY; CONTROLLED STUDY; EMULSION; EXPERIMENTAL GUINEA PIG; FEMALE; GUINEA PIG; HEMAGGLUTINATION INHIBITION; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PARVOVIRUS INFECTION; PORCINE PARVOVIRUS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SPLEEN; T LYMPHOCYTE; VACCINATION;

ADJUVANTS, IMMUNOLOGIC; ALUMINUM COMPOUNDS; ANIMALS; GUINEA PIGS; INTERLEUKIN-2; INTERLEUKIN-4; PARVOVIRUS, PORCINE; PROPOLIS; T-LYMPHOCYTES; VACCINES, INACTIVATED; VIRAL VACCINES;

CAVIA; PORCINE PARVOVIRUS;

EID: 79959849692     PISSN: 00088749     EISSN: 10902163     Source Type: Journal    
DOI: 10.1016/j.cellimm.2011.03.020     Document Type: Article

References (34)

1. Martinez C., Dalsgaard K., Lopez de Turiso J.A., Cortes E., Vela C., Casal J.I. Production of porcine parvovirus empty capsids with high immunogenic activity. Vaccine 1992, 10:684-690.
2. Parke C.R., Burgess G.W. An economic assessment of porcine parvovirus vaccination. Aust. Vet. J. 1993, 70:177-180.
3. Gardner I.A., Carpenter T.E., Leontides L., Parsons T.D. Financial evaluation of vaccination and testing alternatives for control of parvovirus-induced reproductive failure in swine. J. Am. Vet. Med. Assoc. 1996, 208:863-869.
4. Leclerc C. New approaches in vaccine development. Comp. Immunol. Microbiol. Infect. Dis. 2003, 26:329-341.
5. Barr T.A., Carlring J., Heath A.W. Co-stimulatory agonists as immunological adjuvants. Vaccine 2006, 24:3399-3407.
6. Storni T., Kundig T.M., Senti G., Johansen P. Immunity in response to particulate antigen-delivery systems. Adv. Drug Deliv. Rev. 2005, 57:333-355.
7. Aguilar J.C., Rodríguez E.G. Vaccine adjuvants revisited. Vaccine 2007, 25:3752-3762.
8. Holmdahl R., Lorentzen J.C., Lu S., Olofsson P., Wester L., Holmberg J., Pettersson U. Arthritis induced in rats with nonimmunogenic adjuvants as models for rheumatoid arthritis. Immunol. Rev. 2001, 184:184-202.
9. Pascual D.M., Morales R.D., Gil E.D., Mũnoz L.M., López J.E., Casanueva O.L.J. Adjuvants: present regulatory challenges. Vaccine 2006, 24:88-89.
10. Lindblad E.B. Aluminium adjuvants in retrospect and prospect. Vaccine 2004, 22:3658-3668.
11. Relyveld E.H., Bizzini B., Gupta R.K. Rational approaches to reduce adverse reactions in man to vaccines containing tetanus and diphtheria toxoids. Vaccine 1998, 16:1016-1023.
12. Sá-Nunes A., Faccioli L.H., Sforcin J.M. Propolis: lymphocyte proliferation and IFN-γ production. J. Ethnopharmacol. 2003, 87:93-97.
13. Sforcin J.M. Propolis and the immune system: a review. J. Ethnopharmacol. 2007, 113:1-14.
14. Vynograd N., Vynograd I., Sosnowski Z. A comparative multi-centre study of the efficacy of propolis, acyclovir and placebo in the treatment of genital herpes (HSV). Phytomedicine 2000, 7:1-6.
15. Simões L.M., Gregório L.E., Da Silva Filho A.A., De Souza M.L., Azzolini A.E., Bastos J.K., Lucisano-Valim Y.M. Effect of Brazilian green propolis on the production of reactive oxygen species by stimulated neutrophils. J. Ethnopharmacol. 2004, 94:59-65.
16. Guo F.B. The modern pharmacological research of propolis. Apicultural Sci. Technol. 2002, 5:21-25.
17. Paulino N., Scremin F.M., Raichaski L.B., Marcucci M.C., Scremin A., Calixto J.B. Mechanisms involved in the relaxant action of the ethanolic extract of propolis in the guinea-pig trachea in vitro. J. Pharm. Pharmacol. 2002, 54:1-9.
18. Joo H.S., Molitor T.W., Leman A.D. Antibody responses of guinea-pigs, rabbits and pigs to inactivated porcine parvovirus vaccines. Vet. Microbiol. 1984, 9:27-33.
19. Wang J.M., Hui Y.L., Wang D.Y., Liu J., Zhang J., Abula S., Zhao B., Ruan S.L. Sulfated modification can enhance the immune-enhancing activity of lycium barbarum polysaccharides. Cell Immun. 2010, 263:219-223.
20. Li X.K., Cui B.A., Chen H.Y., Wei Z.Y., Zheng L.L., Zhao L., Lv X.L. Detection of porcine parvovirus by quantitative real-time PCR assay. Chin. J. Vet. Sci. 2008, 28:1118-1121.
21. Shen Z.Q. The research and application of fowl Cholera propolis inactivated vaccine. Chin. J. Prev. Vet. Med. 1995, 4:27-30.
22. Fischer G., Cleff M.B., Dummer L.A., Paulino N., Paulino A.S., de Oliveira Vilela C., Campos F.S., Storch T., Avila Vargas G.D'., de Oliveira Hübner S., Vidor T. Adjuvant effect of green propolis on humoral immune response of bovines immunized with bovine herpesvirus type 5. Vet. Immunol. Immunopathol. 2007, 116:79-84.
23. Zhao H.Z., Wang T.Y., Li G.W. Study on inactivated vaccine of Pasteurella multocide. J. Anhui Agric. Sci. 2005, 33:853-854.
24. Cox J.C., Coulter A.R. Adjuvants-a classification and review of their modes of action. Vaccine 1997, 15:248-256.
25. Pinto R.A., Arredondo S.M., Bono M.R., Gaggero A.A., Díaz P.V. T Heper 1/T Helper 2 cytokine imbalance in respiratory syncytial virus infection is associated with increased endogenous plasma cortisol. Pediatrics 2006, 117:878-886.
26. Orsolic N., Terzic S., Sver L., Basic I. Polyphenolic compounds from propolis modulate immune responses and increase host resistance to tumor cells. Food Agric. Immunol. 2005, 16:165-179.
27. Fischer G., Conceição F.R., Leite F.P., Dummer L.A., Vargas G.D., Hübner Sde O., Paulino N., Paulino A.S., Vidor T. Immunomodulation produced by a green propolis extract on humoral and cellular responses of mice immunized with SuHV-1. Vaccine 2007, 25:1250-1256.
28. Wang D.Y., Li X.R., Xu L.X., Hu Y.L., Zhang B.K., Liu J.G. Immunologic synergism with IL-2 and effects of cCHMIs on mRNA expression of IL-2 and IFN-γ in chicken peripheral T lymphocyte. Vaccine 2006, 24:7109-7114.
29. Blonska M., Bronikowska G., Pietsz G., Czuba Z.P., Scheller S., Krol W. Effects of ethanol extract of propolis (EEP) and its flavones on inducible gene expression in J774A.1 macrophages. J. Ethnopharmacol. 2004, 91:25-30.
30. Merz D.C., Scheid A., Choppin P.W. Immunological studies of the functions of paramyxovirus glycoprotein. Virology 1981, 109:94-105.
31. Sforcin J.M., Orsi R.O., Bankova V. Effect of propolis, some isolated compounds and its source plant on antibody production. J. Ethnopharmacol. 2005, 98:301-305.
32. Schlegel M., Vernazza P.L. Immune response, vaccine efficiency. Vaccine 1998, 16:1256.
33. Ansorge S., Reinhold D., Lendeckel U. Propolis and some of its constituents down-regulate DNA synthesis and inflammatory cytokine production but induce TGF-1 production of human immune cells. Z Naturforsch C. 2003, 58:580-589.
34. Hu J.W., Li X.T. The present research situation and development prospect of propolis applied in animal husbandry. J. Tradit. Chin. Vet. Med. 2003, 6:42-43.